Changes in skeletal muscle mass during PD-1 and PD-L1 checkpoint inhibitor therapy in advanced-stage non-small cell lung cancer patients von Multani, Maneet, Tarhoni, Imad, Fughhi, Ibdihaj, Basu, Sanjib, Batus, Marta, Bonomi, Philip D., Fidler, Mary J., Borgia, Jeffrey Allen, Shah, Palmi

Volltext

Differences in circulating angiogenic biomarkers as prognosticator for outcome in bevacizumab-treated nonsquamous non-small cell lung cancer (NSCLC) patients von Batus, Marta, Pithadia, Ravi, Kubasiak, John, Fhied, Cristina, Ibrahem, Zahraa, Melinamani, Shruthi, Fughhi, Ibdihaj, Lie, Wen-Rong, Basu, Sanjib, Fidler, Mary J., Bonomi, Philip D., Borgia, Jeffrey Allen

Volltext